<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Association of anticholinergic load with impairment of complex attention and memory in schizophrenia</dc:title>
  <dc:creator>MINZENBERG, Michael J</dc:creator>
  <dc:creator>POOLE, John H</dc:creator>
  <dc:creator>BENTON, Cynthia</dc:creator>
  <dc:creator>VINOGRADOV, Sophia</dc:creator>
  <dc:relation>The American journal of psychiatry -- Am. j. psychiatr, CODEN AJPSAO, ISSN 0002-953X, Vol. 161 (1) , pp. 116-124</dc:relation>
  <dc:date>2004</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>American Psychiatric Association</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>9 p. ; 47 ref</dc:format>
  <dc:subject xml:lang="fr">Neuroleptique</dc:subject>
  <dc:subject xml:lang="fr">Psychose</dc:subject>
  <dc:subject xml:lang="fr">Psychotrope</dc:subject>
  <dc:subject xml:lang="fr">Accord interjuge</dc:subject>
  <dc:subject xml:lang="fr">Anticholinestérasique</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Etude comparative</dc:subject>
  <dc:subject xml:lang="fr">Facteur risque</dc:subject>
  <dc:subject xml:lang="fr">Fidélité test</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Mécanisme action</dc:subject>
  <dc:subject xml:lang="fr">Psychométrie</dc:subject>
  <dc:subject xml:lang="fr">Psychopharmacologie</dc:subject>
  <dc:subject xml:lang="fr">Psychose schizoaffective</dc:subject>
  <dc:subject xml:lang="fr">Schizophrénie</dc:subject>
  <dc:subject xml:lang="fr">Test neuropsychologique</dc:subject>
  <dc:subject xml:lang="fr">Toxicité</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Trouble cognition</dc:subject>
  <dc:subject xml:lang="fr">Validation test</dc:subject>
  <dc:subject xml:lang="fr">Validité construct</dc:subject>
  <dc:subject xml:lang="fr">Validité convergente</dc:subject>
  <dc:subject xml:lang="en">Neuroleptic</dc:subject>
  <dc:subject xml:lang="en">Psychosis</dc:subject>
  <dc:subject xml:lang="en">Psychotropic</dc:subject>
  <dc:subject xml:lang="en">Interrater agreement</dc:subject>
  <dc:subject xml:lang="en">Anticholinesterase agent</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Comparative study</dc:subject>
  <dc:subject xml:lang="en">Risk factor</dc:subject>
  <dc:subject xml:lang="en">Test reliability</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Mechanism of action</dc:subject>
  <dc:subject xml:lang="en">Psychometrics</dc:subject>
  <dc:subject xml:lang="en">Psychopharmacology</dc:subject>
  <dc:subject xml:lang="en">Schizoaffective psychosis</dc:subject>
  <dc:subject xml:lang="en">Schizophrenia</dc:subject>
  <dc:subject xml:lang="en">Neuropsychological test</dc:subject>
  <dc:subject xml:lang="en">Toxicity</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Cognitive disorder</dc:subject>
  <dc:subject xml:lang="en">Test validation</dc:subject>
  <dc:subject xml:lang="en">Construct validity</dc:subject>
  <dc:subject xml:lang="en">Convergent validity</dc:subject>
  <dc:subject xml:lang="es">Neuroléptico</dc:subject>
  <dc:subject xml:lang="es">Psicosis</dc:subject>
  <dc:subject xml:lang="es">Psicotropo</dc:subject>
  <dc:subject xml:lang="es">Acuerdo interjuez</dc:subject>
  <dc:subject xml:lang="es">Anticolinesterasa agente</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Estudio comparativo</dc:subject>
  <dc:subject xml:lang="es">Factor riesgo</dc:subject>
  <dc:subject xml:lang="es">Fidelidad pruebra</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Mecanismo acción</dc:subject>
  <dc:subject xml:lang="es">Psicometría</dc:subject>
  <dc:subject xml:lang="es">Psicofarmacología</dc:subject>
  <dc:subject xml:lang="es">Psicosis esquizoafectiva</dc:subject>
  <dc:subject xml:lang="es">Esquizofrenia</dc:subject>
  <dc:subject xml:lang="es">Prueba neuropsichologica</dc:subject>
  <dc:subject xml:lang="es">Toxicidad</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject xml:lang="es">Trastorno cognitivo</dc:subject>
  <dc:subject xml:lang="es">Validación prueba</dc:subject>
  <dc:subject xml:lang="es">Validez construct</dc:subject>
  <dc:subject xml:lang="es">Validez convergent</dc:subject>
  <dc:subject>002B18B01: Psychométrie. Systèmes d'aide au diagnostic / Psychometrics. Diagnostic aid systems</dc:subject>
  <dc:subject>770-: Psychologie. Psychanalyse. Psychiatrie / Psychology. Psychoanalysis. Psychiatry</dc:subject>
  <dc:subject>770-D: PSYCHOPATHOLOGIE. PSYCHIATRIE / Psychopathology. Psychiatry</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 15631929</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>